SLC35F5 Activators
L-α-Phosphatidylinositol-4,5-bisphosphate sodium salt and Phorbol esters (PMA) play pivotal roles in altering the membrane dynamics and activating protein kinases, respectively, which can lead to changes in protein phosphorylation. This post-translational modification is a common regulatory mechanism for solute carrier proteins, affecting their activity, localization, and stability. By influencing kinase activity, Forskolin, through the elevation of cAMP levels, and Ionomycin, by increasing intracellular calcium, can induce a cascade of phosphorylation events. These events may alter the conformation of SLC35F5, thereby affecting its transport efficiency.
Similarly, Okadaic Acid, by inhibiting protein phosphatases, ensures that phosphorylated states of proteins are maintained, which could indirectly sustain the activated state of SLC35F5. On the other hand, compounds like Genistein and Sodium orthovanadate modulate tyrosine phosphorylation, which can be critical for the activity of certain solute carriers. Calmodulin inhibitors, through their influence on calcium signaling proteins, can also affect the transport activity indirectly. Additionally, agents such as Epidermal Growth Factor (EGF) can elicit broader changes in protein function by triggering gene expression changes or inducing protein modifications that can influence the activity of transporters like SLC35F5. In the same vein, cGMP analogs and A23187 (Calcimycin) exploit the second messenger systems and ion gradients to exert their effects, which could extend to the modulation of SLC35F5 activity.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
This ionophore can increase intracellular calcium concentrations, which could activate calcium-dependent protein kinases that may phosphorylate and modulate the activity of SLC35F5. | ||||||
Okadaic Acid | 78111-17-8 | sc-3513 sc-3513A sc-3513B | 25 µg 100 µg 1 mg | $291.00 $530.00 $1800.00 | 78 | |
A potent inhibitor of protein phosphatases PP1 and PP2A, Okadaic Acid can lead to increased phosphorylation levels of cellular proteins, which can include transport proteins, potentially modulating their activity. | ||||||
W-7 | 61714-27-0 | sc-201501 sc-201501A sc-201501B | 50 mg 100 mg 1 g | $166.00 $306.00 $1675.00 | 18 | |
Calmodulin is a calcium-binding messenger protein that can influence various cellular processes. Inhibitors of calmodulin may affect signaling pathways that indirectly modulate the activity of SLC35F5. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
As activators of protein kinase C (PKC), Phorbol esters can phosphorylate a broad range of cellular proteins, which may include SLC35F5, thereby influencing its activity. | ||||||
8-Bromoguanosine 3′, 5′ -cyclic monophosphoric acid | 31356-94-2 | sc-291685 sc-291685A | 5 mg 10 mg | $116.00 $206.00 | ||
These analogs can activate cGMP-dependent protein kinases, which could lead to the modulation of the activity of various proteins, including potentially SLC35F5. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
A tyrosine kinase inhibitor, Genistein can alter cellular signaling pathways and potentially affect the phosphorylation and activity of proteins, including SLC35F5. | ||||||
Sodium Orthovanadate | 13721-39-6 | sc-3540 sc-3540B sc-3540A | 5 g 10 g 50 g | $49.00 $57.00 $187.00 | 142 | |
An inhibitor of protein tyrosine phosphatases, Sodium orthovanadate can enhance tyrosine phosphorylation of proteins, which may affect the activity of SLC35F5. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
This calcium ionophore can increase intracellular calcium levels, which might activate calcium-sensitive proteins and signaling pathways, possibly influencing the activity of SLC35F5 indirectly. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
An inhibitor of the PI3K/Akt pathway, LY294002 can alter the phosphorylation status of various proteins and could indirectly influence the activity of SLC35F5 through changes in cellular signaling. | ||||||